Ameritas Investment Company’s Biomerica BMRA Stock Holding History

Ameritas Investment Company’s Portfolio BMRA Stock Details BMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-2	Closed	–	–	470
2020 Q1	$0	Buy	+2	New	+$61	﹤0.01%	1760

Other funds holding BMRA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

HIMC

Heritage Investors Management Corp Bethesda, Maryland $3.61B AUM 35.86% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

PCM

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ameritas Investment Company's BMRA Position: Q2 2020 in Review

Ameritas Investment Company sold out of Biomerica (BMRA) in Q2 2020, closing a stake of 2 shares.

Ameritas Investment Company first reported a position in BMRA in Q1 2020 and held it in 1 quarter. The position peaked at $0 in Q1 2020. 27 funds tracked by Wall St. Rank hold BMRA as of Q2 2020.

Ameritas Investment Company reported no remaining Biomerica position as of Q2 2020 after selling out during the quarter.
Ameritas Investment Company sold 2 Biomerica shares in Q2 2020.
Ameritas Investment Company first reported a position in Biomerica in Q1 2020 and held it in 1 quarter.
Ameritas Investment Company's Biomerica position peaked at $0 in Q1 2020.
27 funds tracked by Wall St. Rank held Biomerica as of Q2 2020.

Based on Ameritas Investment Company's 13F filing for Q2 2020, filed 14 Aug 2020.